Order number: 345H.1
Part number: AC100008913
Engineered to maintain reliability in process-driven workflows, the HPLC column NUCLEODUR® C 8 Gravity, 5 μm, 250 mm, 2 mm offers exceptional performance for reversed phase separations. Its base deactivated (BDS) surface chemistry, combined with a high density C 8 phase, ensures minimal unwanted polar interactions, making it ideal for the separation of basic and ionizable analytes. With a pH stability range of 1.0-11.0, this column is an excellent choice for method development and RP applications, especially those involving extreme pH values. Furthermore, its pressure stability up to 600 bar and temperature stability up to 60°C ensure robustness in various conditions.
| Name | Value | |
|---|---|---|
| Phase | : | C 8 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L7 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.8 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 8 HD Xterra ® RP 8 / MS C 8 Luna ® C 8 Zorbax ® Eclipse XDB-C 8 |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density monomeric octyl (C 8 , MOS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 250 x 2 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.